Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
G-protein coupled receptor (GPCR) kinase-2 interacting protein 1 (GIT1) is a multifunctional scaffolding protein that regulates epidermal growth factor receptor (EGFR) signaling pathways. We demonstrate that GIT1 interacts with
sorting nexin 6
(
SNX6
), a member of the SNX family that increases EGFR trafficking between endosomes and lysosomes, thereby enhancing EGFR degradation. The GIT1-
SNX6
interaction is increased 3-fold after treatment with EGF for 60 min. The second coiled-coil domain (CC2; aa 424-474) of GIT1 mediates binding to
SNX6
. Subcellular fractionation and confocal microscopy data indicate that GIT1 and
SNX6
interact in endosomes. Knockdown of GIT1 expression by small interfering RNA decreased the rate of EGF-induced EGFR degradation. Expression of exogenous GIT1 or
SNX6
alone did not alter EGFR degradation; however, coexpression of GIT1 and
SNX6
decreased EGFR levels both basally and in response to EGF. In contrast, expression of GIT1(CC2 deleted) and
SNX6
did not reduce EGFR levels, demonstrating that the interaction between GIT1 and
SNX6
was required to regulate EGFR trafficking. Phosphorylation of the EGFR substrate
phospholipase C
-gamma was decreased by coexpression of GIT1 and
SNX6
. These data demonstrate an endosomal, EGF-regulated interaction between
SNX6
and GIT1 that enhances degradation of the EGFR, and thereby alters EGFR signaling. Our findings suggest a new role for GIT1 in tyrosine kinase receptor trafficking.
...
PMID:An epidermal growth factor (EGF) -dependent interaction between GIT1 and sorting nexin 6 promotes degradation of the EGF receptor. 1852 62